QGEN Qiagen
- Official Name: Qiagen NV
- Headquarters: 19300 Germantown Rd Germantown MARYLAND 20874, US
- CEO: Thierry Bernard
- Website: qiagen.com
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-15 | 1R | Lost by 0.537 | (1.552) - (1.015) | ||
| 2025-07-16 | 1 | Lost by 6.218 | 0.566 - 6.784 | ||
| 2025-07-23 | 2 | Won by 2.664 | 3.879 - 1.215 | ||
| 2025-07-30 | 3 | Lost by 6.301 | (11.214) - (4.913) | ||
| 2025-08-06 | 4 | Lost by 3.892 | (2.062) - 1.830 | ||
| 2025-08-13 | 5 | Lost by 0.526 | (0.826) - (0.300) | ||
| 2025-08-20 | 6 | Lost by 4.845 | (6.746) - (1.901) | ||
| 2025-08-27 | 7 | Lost by 5.735 | (2.702) - 3.033 | ||
| 2025-09-03 | 8 | Won by 8.769 | (2.339) - (11.108) | ||
| 2025-09-10 | 9 | Won by 2.466 | (1.515) - (3.981) | ||
| 2025-09-17 | 10 | Won by 0.432 | (1.431) - (1.863) | ||
| 2025-09-24 | 11 | Lost by 0.428 | (0.734) - (0.306) | ||
| 2025-10-01 | 12 | Won by 5.837 | 2.682 - (3.155) | ||
| 2025-10-08 | 13 | Won by 9.163 | 3.714 - (5.449) | ||
| 2025-10-15 | 14 | Won by 3.500 | (0.531) - (4.031) | ||
| 2025-10-22 | 15 | Won by 2.010 | 2.333 - 0.323 |
Latest News
Yahoo - 2026-09-28
Qiagen (QGEN), What Is Behind The Fresh Attention Now?
Qiagen (NYSE:QGEN) just received U.S. FDA clearance for its QIAstat-Dx gram-negative bloodstream infection panel, giving American laboratories full ac...
Yahoo - 2026-09-28
What Qiagen (QGEN)'s Expanded Sepsis Testing Portfolio Means For Shareholders
Earlier this week, QIAGEN announced that U.S. labs now have access to its full QIAstat-Dx bloodstream infection portfolio after FDA clearance of a one...
Yahoo - 2026-09-28
Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership
Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high...
Yahoo - 2026-09-28
QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel
GERMANTOWN, Md. & VENLO, Netherlands, September 28, 2026--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that U.S. labora...
Benzinga - 2026-09-27
FDA Clears QIAGEN's Gram-Negative QIAstat-Dx Bloodstream Panel, Joining Gram-Positive And Fungal Panel To Cover 33 Pathogen Targets And 28 Resistance Marker
Bloodstream infections can trigger sepsis, a life-threatening response to infection; about 1.7 million U.S. adults develop sepsis each year, contribut...
Yahoo - 2026-09-24
QIAGEN Launches QIAmini to Automate Small-Batch Sample Preparation
VENLO, Netherlands & GERMANTOWN, Md., September 24, 2026--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QI...
Show more
Yahoo - 2026-09-24
Here's Why You Should Hold QIAGEN Stock in Your Portfolio for Now
ChartMill - 2026-09-24
QIAGEN (NYSE:QGEN) Eyes Breakout With Technical Rating 7 and Setup Rating 9
Yahoo - 2026-09-18
QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board
Yahoo - 2026-09-18
Genomics Market Outlook 2026-2035 - Featuring Profiles of Illumina, Thermo Fisher Scientific, and Qiagen
Yahoo - 2026-09-18
Pharmacogenomics Market Outlook 2026-2035 - Featuring Profiles of Thermo Fisher Scientific, Illumina, and Qiagen
Yahoo - 2026-09-17
QIAGEN (QGEN) Rolls Out QIAsymphony Connect Following Q2 Outperformance
SeekingAlpha - 2026-09-16
Qiagen N.V. (QGEN) Presents at 2026 Global Healthcare Conference Transcript
SeekingAlpha - 2026-09-14
Qiagen N.V. (QGEN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Yahoo - 2026-09-10
Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead
Benzinga - 2026-09-09
UBS Maintains Neutral on Qiagen, Lowers Price Target to $47
Yahoo - 2026-09-08
ILMN Stock Keeps Climbing. Should You Climb On?
Yahoo - 2026-09-05
Qiagen (QGEN) Beat Q2 Estimates And Reaffirmed Outlook, Is It Still Below Fair Value?
Yahoo - 2026-09-05
How Qiagen’s New Automation Platform, CEO Transition and Q2 Beat Will Impact Qiagen (QGEN) Investors
Yahoo - 2026-09-04
Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue?
Yahoo - 2026-09-04
Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share
Yahoo - 2026-09-01
Plant Virome Diagnostics Outlook 2026-2030 Featuring Profiles of Illumina, Thermo Fisher Scientific and Qiagen
Yahoo - 2026-08-31
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
Benzinga - 2026-08-31
Jury Awards 10x Genomics Millions in Patent Lawsuit Against Qiagen Unit
Yahoo - 2026-08-28
Could Qiagen (QGEN) Stock Win as Its FDA Clearance Opens a New Diagnostics Market?
Yahoo - 2026-08-28
10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences
Benzinga - 2026-08-28
10x Genomics Wins Patent Case Against Parse Biosciences As Jury Finds Willful Infringement And Awards $4.8M+ In Damages; Company To Seek Enhanced Damages, Fees And Permanent Injunction
Yahoo - 2026-08-27
QIAGEN Launches QIAsymphony Connect for Automated Clinical Nucleic Acid Extraction
Yahoo - 2026-08-25
Qiagen names new CEO
Yahoo - 2026-08-24
Qiagen names Jonathan Pratt as CEO amid takeover talks
Yahoo - 2026-08-24
QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer
Benzinga - 2026-08-24
QIAGEN Appoints Jonathan M. Pratt CEO, Effective Sept. 1, Succeeding Thierry Bernard; Co. Reiterates Q3, FY26 Guidance
Yahoo - 2026-08-20
Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?
Yahoo - 2026-08-13
Qiagen (QGEN) Beat Its Own Guidance, So Why Did Margins Slip?
Yahoo - 2026-08-13
Strong Beats Mask Zillow’s (Z) Restructuring And Headwinds
Yahoo - 2026-08-13
Will FDA Clearance of QIAstat-Dx Bloodstream Panel Change Qiagen's (QGEN) Syndromic Testing Narrative?
Yahoo - 2026-08-13
Qiagen (QGEN) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-10
QIAGEN Receives U.S. FDA Clearance for First QIAstat-Dx Bloodstream Infection Panel
Benzinga - 2026-08-10
QIAGEN Says FDA Clears QIAstat-Dx BCID GPF Plus AMR Panel For Bloodstream Infections
Yahoo - 2026-08-10
Understanding Qiagen (QGEN) Reliance on International Revenue
Benzinga - 2026-08-10
Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45
Yahoo - 2026-08-08
Qiagen Q2 Earnings Call Highlights
Benzinga - 2026-08-07
Barclays Maintains Equal-Weight on Qiagen, Raises Price Target to $40
Benzinga - 2026-08-07
JP Morgan Maintains Overweight on Qiagen, Raises Price Target to $50
Benzinga - 2026-08-06
Conference Call: Qiagen Q3 Adj EPS expected to be more than $0.62 vs $0.64 Est; Sees Q3 Sales $538.330M-$543.660M vs $552.590M Est
SeekingAlpha - 2026-08-06
Qiagen N.V. (QGEN) Q2 2026 Earnings Call Transcript
Yahoo - 2026-08-06
Qiagen N.V. Q2 2026 Earnings Call Summary
SeekingAlpha - 2026-08-06
Qiagen N.V. 2026 Q2 - Results - Earnings Call Presentation
Yahoo - 2026-08-05
Qiagen (QGEN) Beats Q2 Earnings and Revenue Estimates
Yahoo - 2026-08-05
Qiagen (QGEN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Yahoo - 2026-08-05
QIAGEN Exceeds Q2 2026 Outlook as Pillars Deliver Solid Sales Growth; Reaffirms Full-Year Outlook
Benzinga - 2026-08-05
Qiagen FY2026 Adj EPS expected to be more than $2.43 vs $2.42 Est; Affirms FY2026 Sales Guidance of $2.111B-$2.132B vs $2.139B Est
Benzinga - 2026-08-05
Qiagen Q2 Adj. EPS $0.62 Beats $0.60 Estimate, Sales $535.000M Beat $527.484M Estimate
Yahoo - 2026-07-30
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Yahoo - 2026-07-29
Analysts Estimate Qiagen (QGEN) to Report a Decline in Earnings: What to Look Out for
SeekingAlpha - 2026-07-22
Cyclosporiasis: Investing In Biosecurity
Yahoo - 2026-07-22
KKR (KKR) Launches Allyntra While Chasing DStelecom And Qiagen
Yahoo - 2026-07-17
Cancer Biomarkers Market to Reach US$ 54.48 Billion by 2032 as Precision Oncology and Multi-Omics Adoption Accelerate
Yahoo - 2026-07-15
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
Yahoo - 2026-07-15
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
Yahoo - 2026-07-14
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe
SeekingAlpha - 2026-07-12
Qiagen: New Launches Signal A Turnaround
Yahoo - 2026-07-10
Qiagen (QGEN) Takeover Talk Puts Valuation Back In Focus
Benzinga - 2026-07-10
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Yahoo - 2026-07-09
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo - 2026-07-09
QGEN Stock Clocks Biggest Single-Day Gains In Nearly Six Months – Investor Optimism Jumps On Report About Takeover Interest
Yahoo - 2026-07-09
Update: Market Chatter: Qiagen Attracts Early Takeover Interest From EQT, Advent, KKR
Benzinga - 2026-07-09
'Qiagen Draws Early Takeover Interest From EQT, Advent' - Bloomberg
Fintel - 2026-06-26
Morgan Stanley Upgrades Qiagen N.V. (QGEN)
SeekingAlpha - 2026-06-24
Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis - Slideshow
SeekingAlpha - 2026-06-24
Qiagen N.V. (QGEN) Shareholder/Analyst Call - Slideshow
SeekingAlpha - 2026-06-24
Qiagen N.V. (QGEN) Shareholder/Analyst Call Transcript
Benzinga - 2026-06-23
Morgan Stanley Upgrades Qiagen to Overweight, Raises Price Target to $42
Yahoo - 2026-06-23
IBM upgrade, SpaceX initiation among today's top calls on Wall Street
SeekingAlpha - 2026-06-18
Qiagen N.V. (QGEN) Presents at JP Morgan European Healthcare Conference 2026 - Slideshow
SeekingAlpha - 2026-06-15
Qiagen N.V. (QGEN) Discusses Digital PCR Technology and Applications in Environmental Sample Analysis Transcript
Yahoo - 2026-06-15
QIAGEN Expands QIAcuity Gene Expression Portfolio to Drive dPCR Use
Yahoo - 2026-06-15
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
Benzinga - 2026-06-14
QIAGEN Expands QIAcuity Digital PCR Portfolio Into Gene Expression, Cell And Gene Therapy And Automated Workflows To Drive Broader Adoption Across Life Sciences
Yahoo - 2026-06-05
Qiagen (QGEN) Up 12.1% Since Last Earnings Report: Can It Continue?
SeekingAlpha - 2026-06-03
Qiagen N.V. (QGEN) Presents at Jefferies Global Healthcare Conference 2026 Transcript
SeekingAlpha - 2026-06-01
Qiagen N.V. (QGEN) Presents at Deutsche Bank German Corporate Conference - Slideshow
Yahoo - 2026-05-29
Is QGEN Stock a Hold After the 2026 Outlook Cut and Q1 Miss?
Yahoo - 2026-05-28
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
Yahoo - 2026-05-28
QIAGEN Business Breakdown and Growth Drivers for 2026
Yahoo - 2026-05-21
NVIDIA Qiagen Alliance Extends AI Reach Into Drug Discovery Workflows
Yahoo - 2026-05-20
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
Yahoo - 2026-05-20
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
Yahoo - 2026-05-20
QIAGEN and NVIDIA partner on AI drug discovery
Yahoo - 2026-05-19
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
Benzinga - 2026-05-18
Stifel Maintains Hold on Qiagen, Lowers Price Target to $36
Fintel - 2026-05-14
Qiagen N.V. (QGEN) Price Target Decreased by 13.91% to 46.28
Finnhub - 2026-05-13
QGEN Investor Alert: Levi & Korsinsky Investigates Qiagen (QGEN) for Potential Securities Fraud
SeekingAlpha - 2026-05-12
Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Finnhub - 2026-05-12
Transcript : Qiagen N.V. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03
Finnhub - 2026-05-12
Qiagen N.V. Proposes Annual Cash Dividend, Payable on July 14, 2026
Finnhub - 2026-05-12
Qiagen N.V. Announces Metin Colpan Decides Not to Stand for Re-Election of Supervisory Board
Finnhub - 2026-05-12
Qiagen N : 2025 Annual Report 2025 Annual Financial Report
Finnhub - 2026-05-11
Qiagen N : 2025 Remuneration Report
Benzinga - 2026-05-11
QIAGEN's 2026 AGM To Feature 40% Dividend Increase To $0.35/Share, $200M Buyback And Co-Founder Colpan As Honorary Chairman
Finnhub - 2026-05-11
Qiagen to appoint Metin Colpan as honorary chairman of the supervisory board
Finnhub - 2026-05-11
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
Yahoo - 2026-05-11
Deciphering Qiagen (QGEN) International Revenue Trends
Finnhub - 2026-05-11
Qiagen N : Full Q1 2026 Results Investor Introduction
SeekingAlpha - 2026-05-09
Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing - Slideshow
Yahoo - 2026-05-08
Qiagen (NYSE:QGEN) Valuation Check After Extended Share Price Weakness
SeekingAlpha - 2026-05-08
Qiagen N.V. (QGEN) Discusses Strategic Priorities and Latest Developments for QuantiFERON and Latent Tuberculosis Testing Transcript
Finnhub - 2026-05-07
QIAGEN NV : Gets a Neutral rating from Barclays
Finnhub - 2026-05-07
Transcript : Qiagen N.V. - Special Call
Benzinga - 2026-05-07
TD Cowen Maintains Hold on Qiagen, Lowers Price Target to $40
Finnhub - 2026-05-07
QIAGEN NV : Jefferies reaffirms its Buy rating
Finnhub - 2026-05-07
Qiagen N : BofA Securities 2026 Healthcare Conference Investor introduction
Benzinga - 2026-05-07
QIAGEN Plans To Advance QuantiFERON Latent TB Test With Automated Sample To Insight Workflow And Separate AI-Enabled Risk Stratification Tool For TB Progression
Finnhub - 2026-05-07
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
ChartMill - 2026-05-06
QIAGEN N.V. (NYSE:QGEN) Q1 Earnings Miss Estimates, Guidance Cut Sinks Stock
Benzinga - 2026-05-06
UPDATE: Qiagen FY2026 expected to be more than $2.43 vs $2.51 Est; Affirms FY2026 Sales Guidance of $2.111B-$2.132B vs $2.183B Est
Finnhub - 2026-05-06
Qiagen: Q1 Earnings Snapshot
Benzinga - 2026-05-06
Earnings Scheduled For May 6, 2026
Finnhub - 2026-05-06
QIAGEN Reports Full Results for Q1 2026
Finnhub - 2026-05-06
Qiagen NV reports full results for Q1 2026
Finnhub - 2026-05-06
Qiagen Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Qiagen N.V. (QGEN)
Finnhub - 2026-04-30
Qiagen N : 2025 Annual Report 2025 IFRS Annual Report
Fintel - 2026-04-29
Baird Upgrades Qiagen N.V. (QGEN)
Benzinga - 2026-04-29
JP Morgan Maintains Overweight on Qiagen, Lowers Price Target to $45
Benzinga - 2026-04-29
Citigroup Maintains Neutral on Qiagen, Lowers Price Target to $38
Benzinga - 2026-04-29
Barclays Maintains Equal-Weight on Qiagen, Lowers Price Target to $38
Benzinga - 2026-04-29
This Crane Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Benzinga - 2026-04-29
Starbucks To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Finnhub - 2026-04-29
QIAGEN NV : DZ Bank gives a Buy rating
Benzinga - 2026-04-29
Baird Upgrades Qiagen to Outperform, Lowers Price Target to $43
Finnhub - 2026-04-28
QIAGEN NV : Barclays reiterates its Neutral rating
SeekingAlpha - 2026-04-28
Qiagen N.V. (QGEN) Q1 2026 Earnings Call Transcript
Finnhub - 2026-04-28
QIAGEN NV : Jefferies keeps its Buy rating
Benzinga - 2026-04-28
Stock Market Today: S&P 500 Drops Amid Tech Sell-Off, Oil Climbs To $100 On Hormuz Drama
Finnhub - 2026-04-28
Transcript : Qiagen N.V., Q1 2026 Earnings Call, Apr 28, 2026
SeekingAlpha - 2026-04-28
Qiagen N.V. 2026 Q1 - Results - Earnings Call Presentation
Finnhub - 2026-04-28
Preliminary Q1 2026 Results Conference Call Presentation: Tuesday, April 28, 2026
Finnhub - 2026-04-28
Qiagen: Weak Q1 and guidance cut unsettle the market
Finnhub - 2026-04-28
QIAGEN NV : Deutsche Bank remains its Buy rating
Finnhub - 2026-04-27
QIAGEN NV : Jefferies gives a Buy rating
Finnhub - 2026-04-27
Qiagen N : hoc Announcement according to Art. 17 Market Abuse Regulation
Finnhub - 2026-04-27
QIAGEN NV : Barclays remains Neutral
Finnhub - 2026-04-27
Preliminary Q1 2026 Results Webcast Dial-in Details: Tuesday, April 28, 2026
Finnhub - 2026-04-27
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
Finnhub - 2026-04-16
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
Finnhub - 2026-04-15
Qiagen N : Sustainability Report (qiagen uk gender pay 2025 website v3)
Fintel - 2026-04-14
Barclays Downgrades Qiagen N.V. (QGEN)
Finnhub - 2026-04-14
Qiagen N.V. Expands into Bloodstream Infection Syndromic Testing with New Rapid QIAstat-Dx Panel
Finnhub - 2026-04-14
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
Benzinga - 2026-04-14
Barclays Downgrades Qiagen to Equal-Weight, Announces $44 Price Target
Finnhub - 2026-04-14
QIAGEN NV : Barclays is less optimistic
Yahoo - 2026-04-02